⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
ClpP-Based Mitochondria-Targeted PROTACs
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-07-09 — Cell-Type-Specific Calibration of Mitochondrial Ubiquitination in Stem Cell Fate Decisions.: 2025 review frames ClpP-based mitochondria-targeted PROTACs as a complementary degradation arm to PINK1–Parkin/USP30 modulation, arguing calibrated mitochondrial protein turnover governs stem-cell self-renewal versus senescence (mechanistic synthesis, no in vivo aging outcomes). [mechanism-plausible] (novelty: 3)
Open questions
Related
Contributing findings
Cell-Type-Specific Calibration of Mitochondrial Ubiquitination in Stem Cell Fate Decisions.
09-jul-2026
novelty 3
per-area 3
strengthens